Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenib

被引：0
|
作者：
Wada, Y. [1 ]
Takami, Y. [1 ]
Matsushima, H. [1 ]
Ryu, T. [1 ]
Mikagi, K. [1 ]
Saitsu, H. [1 ]
机构：
[1] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Dept Hepatobiliary Pancreat Surg, Fukuoka, Japan
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31709-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-103
引用
收藏
页码：S630 / S631
页数：2
相关论文
共 50 条
  • [41] Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression
    Kondo, Masaaki
    Numata, Kazushi
    Hara, Koji
    Nozaki, Akito
    Fukuda, Hiroyuki
    Chuma, Makoto
    Maeda, Shin
    Tanaka, Katsuaki
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017, 2017
  • [42] PET-MR can predict survival and response in advanced hepatocellular carcinoma patients treated with sorafenib
    Hwang, Jae-Pil
    Lim, Ilhan
    Han, Chul Ju
    Park, Su Cheol
    Kim, Young Han
    Park, Joon Yeun
    Kim, Kyeong Min
    Kim, Byung Il
    Choi, Chang Woon
    Lim, Sang Moo
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [43] Early alpha-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Lee, Sangheun
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2015, 2 : 39 - +
  • [44] Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials
    Zhang, Tao
    Ding, Xin
    Wei, Dong
    Cheng, Peng
    Su, Xiaomei
    Liu, Huanyi
    Wang, Daoyuan
    Gao, Hui
    ANTI-CANCER DRUGS, 2010, 21 (03) : 326 - 332
  • [45] A multicenter analysis of prognostic factors in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib.
    Smith, Alan D.
    Chan, Kelvin K.
    Lim, Howard John
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Survival of Patients with Advanced Hepatocellular Carcinoma on Sorafenib: Retrospective Analysis from a Single Asian Center
    Ha, Yeonjung
    Lee, Danbi
    Shim, Ju Hyun
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Kim, Kang Mo
    HEPATOLOGY, 2015, 62 : 435A - 435A
  • [47] Analysis of clinical parameters as predictor of outcome in sorafenib-treated patients with advanced hepatocellular carcinoma
    Cho, Ju Yeon
    Paik, Yong Han
    Lim, Ho Young
    Min, Yang Won
    Gwak, Geum-Youn
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    HEPATOLOGY, 2012, 56 : 462A - 462A
  • [48] Biomarker analysis using circulating tumor DNA in patients treated with sorafenib for advanced hepatocellular carcinoma
    Park, S. R.
    Oh, C. R.
    Kong, S-Y.
    Kim, M. K.
    Yoon, K-A.
    Cho, E.
    Jang, J-H.
    Lee, J.
    Ryoo, B-Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Survival analysis of sorafenib combined with TACE in hepatocellular carcinoma patients
    Cao, Jingqin
    Zhang, Defen
    Zhang, Yingchun
    Yue, Yanxiao
    Cai, Huaizhuang
    Zhang, Jie
    Wang, Zuoxiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (09): : 6823 - 6828
  • [50] The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib
    Ruanglertboon, Warit
    Sorich, Michael J.
    Logan, Jessica M.
    Rowland, Andrew
    Hopkins, Ashley M.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (10) : 2693 - 2697
12345